MedTrace Logo

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

NCT03000998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2023-02-06

No results posted yet for this study

Summary

The uptake of vaccines for Human Papillomavirus (HPV) in the U.S. is far below recommended levels, particularly for adolescent boys and especially among minority families. Proposed here is a mobile web application ("mobile web app") for personal computers, smart phones, and tablet computers that will accurately inform parents and adolescent boys about the HPV vaccination and address unique concerns about its safety and effectiveness for boys. The BoyVac mobile web app will be evaluated for its ability to improve vaccine outcomes in a randomized efficacy trial with parents and adolescent boys aged 11-13 years.

Conditions

  • Human Papillomavirus Virus
  • HPV

Interventions

BEHAVIORAL

Web App Intervention Group

All baseline and follow-up data collection will be conducted via online surveys and a customized web portal and include parent self-reports and clinic records of vaccination of boys

BEHAVIORAL

Usual Customary Care Group

Participants randomized to the usual and customary care (UC) group will receive a website with a pamphlet on HPV vaccination from the Centers for Disease Control and Prevention (CDC) in Portable Document Format (PDF) format.

Sponsors & Collaborators

  • University of New Mexico

    collaborator OTHER

  • Indiana University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • Gill Woodall, PhD · Klein Buendel, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000998 on ClinicalTrials.gov